实验室提供Delta睡眠诱导肽(DSIP)
议价
加入意向| 型号。 | API |
| 定制 | 定制 |
| 适合 | 成人 |
| 纯度 | >98% |
| 其他名称 | DSIP |
| 出现 | 白色粉末 |
| 类型 | 医药中间体 |
| 保质期 | 2年 |
| 运输包装 | 框 |
| 起源 | 上海 |
| 粉末 | 是 |
| 证明 | gmp,hse,iso 9001,usp,bp |
| 州 | 固体 |
| 没有 | 62568-57-4 |
| MF | C35h48n10o15 |
| 发源地 | 上海中国(大陆) |
| 纯度 | 超过98% |
| 型号 | 肽 |
| 规范 | 为2mg /瓶 |
| HS编码 | 3001909099 |
名称:DSIP
其他名字三角洲睡眠诱导肽
cas:62568-57-4
序列:trp-ala-gly-gly-asp-ala-ser-gly-glu
mf:c35h48n10o15
mw:848.813620
纯度:99%
外观:白色冻干粉
原产地:中国
标准:USP
认证:SGS
分析方法:HPLC
储存:尽管在室温下稳定3个月,但冻干肽应储存至-18°C以下。储存在肽中后,应在4℃保存2-21天,以备日后使用-18°C -18℃; C.w -18° C.
用法:
DSIP(Delta睡眠诱导肽)是在下丘脑,垂体和肾上腺中发现的神经肽。
其隔离已经允许进行广泛的研究,已经发现该肽的几种可能的初级和周期性作用。
首先,DSIP已被证明 诱导睡眠。第二,它可能作为止痛剂治疗慢性疼痛有好处,
有时作为辅助治疗。第三,DSIP已经被证明阻止ACTH释放并降低ACTH水平,刺激LH释放,并作为抑制剂 生长抑素的分泌。
DSIP的生产来源尚不清楚;它可能在中枢神经系统或周围器官中产生。它被认为通过了. 通过血脑屏障(BBB)比大多数已知的神经肽更容易。
如上所述,DSIP在诱导中显示出积极的结果 慢波EEG(睡眠)。
已被证明有助于治疗发作性睡病并恢复睡眠模式的正常睡眠节奏。





| Model NO. | API |
| Customized | Customized |
| Suitable for | Adult |
| Purity | >98% |
| Other Names | Dsip |
| Appearance | White Powder |
| Type | Pharmaceutical Intermediates |
| Shelf Life | 2 Years |
| Transport Package | Box |
| Origin | Shanghai |
| Powder | Yes |
| Certification | GMP, HSE, ISO 9001, USP, BP |
| State | Solid |
| CAS No | 62568-57-4 |
| Mf | C35h48n10o15 |
| Place of Origin | Shang Hai China (Mainland) |
| The Purity | Over 98% |
| Model No | Peptide |
| Specification | 2mg/vial |
| HS Code | 3001909099 |
Name:Dsip
Other Name: Delta Sleep Inducing Peptide
CAS: 62568-57-4
Sequence: TRP-ALA-GLY-GLY-ASP-ALA-SER-GLY-GLU
MF: C35H48N10O15
MW: 848.813620
Purity: 99%
Appearance: White Lyophilized Powder
Place of Origin: China
Standard: USP
Certification: SGS
Method of Analysis: HPLC
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C.w -18° C.; C.w -18° C.
Usage:
DSIP (Delta Sleep-inducing Peptide) is a neuropeptide found in the hypothalamus, pituitary, and adrenal glands.
Its isolation has allowed for extensive research which has found several possible primary and peripheral roles of this peptide.
First, DSIP has been shown to induce sleep. Second, it may have benefits as an analgesic in treatment of chronic pain,
sometimes as an adjunct treatment. Third, DSIP has been shown to block ACTH release and decrease levels of ACTH, stimulate LH release, and act as an inhibitor of the secretion of somatostatin.
The source of production of DSIP is yet unknown; It may be produced in the central nervous system or in a peripheral organ. It is thought to pass. Through the blood-brain barrier (BBB) more easily than most known neuropeptides.
As mentioned, DSIP has shown positive results in inducing slow-wave EEG (sleep).
It has been shown to help treat narcolepsy and restore disturbed sleep patterns to normal sleep rhythms.




